Becton DickinsonBDX +2.44%76 PEG Ratio is 1.46 as of Jun. 25, 2026, which is 69% below its 10-year median of 4.73. GuruFocus rates BDX with a GF Score™ of 76/100 and a GF Value™ of $191.05 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 208 Medical Devices & Instruments companies, Becton Dickinson ranks better than 59.62% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Becton Dickinson's PEG Ratio or its related term are showing as below:
BDX'
s PEG Ratio Range Over the Past 10 Years
Min: 1.43 Med: 4.73 Max: 836
Current: 1.46
During the past 13 years, Becton Dickinson's highest PEG Ratio was 836.00. The lowest was 1.43. And the median was 4.73.
BDX's PEG Ratio is ranked better than 59.62% of 208
companies
in the Medical Devices & Instruments industry
Industry Median: 1.935
vs BDX: 1.46
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Becton Dickinson (NYSE:BDX) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Becton Dickinson PEG Ratio Related Terms
Becton Dickinson PEG Ratio Historical Data
* Premium members only.
The historical data trend for Becton Dickinson's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Becton Dickinson's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Becton Dickinson PEG Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Becton Dickinson's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Becton Dickinson's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Becton Dickinson (BDX) has a PEG Ratio of 1.46 as of Jun. 25, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Becton Dickinson and its competitors. This is 69% below median its historical median of 4.73. Over the past decade, Becton Dickinson's PEG Ratio has ranged from 1.43 to 836.00. According to the industry distribution chart, Becton Dickinson ranks #84 out of 208 companies in the Medical Devices & Instruments industry, placing it in the top 40.4%.
Is Becton Dickinson's PEG Ratio too high?
Becton Dickinson's current PEG Ratio of 1.46 is 69% below median its 10-year median of 4.73. Over the past 10 years, this metric has ranged from a low of 1.43 to a high of 836.00. The Medical Devices & Instruments industry median PEG Ratio is 1.94. Becton Dickinson's value of 1.46 is 24.5% below this industry median. Based on the distribution chart, Becton Dickinson ranks #84 out of 208 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Becton Dickinson has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Becton Dickinson's PEG Ratio compare to MDLN and RMD?
According to the Medical Devices & Instruments industry distribution chart, Becton Dickinson ranks #84 out of 208 companies for PEG Ratio. This puts Becton Dickinson in the upper half of its industry. The industry median PEG Ratio is 1.94. Becton Dickinson's value of 1.46 is 24.5% below this benchmark. Historically, Becton Dickinson's own PEG Ratio has ranged from 1.43 to 836.00 over the past decade. While the company's 10-year median is 4.73 vs. the industry median of 1.94, Becton Dickinson has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Devices & Instruments company?
The median PEG Ratio among Medical Devices & Instruments companies is 1.94, based on 208 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Becton Dickinson's current PEG Ratio of 1.46 is 24.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Becton Dickinson and its competitors. For the Medical Devices & Instruments industry, the median PEG Ratio is 1.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Becton Dickinson's current PEG Ratio is 1.46, which is 69% below median its own 10-year median of 4.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Becton Dickinson stock overvalued right now?
Based on GuruFocus' analysis, Becton Dickinson (BDX) is currently considered Modestly Undervalued. The stock's GF Value™ is $191.05, compared to a current price of $151.38 — trading 20.8% below its estimated fair value. The current PEG Ratio is 1.46, which is 69% below median its 10-year median of 4.73 and 24.5% below the Medical Devices & Instruments industry median of 1.94. Becton Dickinson's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Becton Dickinson (BDX), the current PEG Ratio is 1.46 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Becton Dickinson (BDX) Overvalued in 2026?
Based on GuruFocus' analysis, Becton Dickinson stock appears to be undervalued.
The current stock price of $151.38 is trading 20.8% below its estimated GF Value™ of $191.05.
GuruFocus considers Becton Dickinson to be Modestly Undervalued.
Key valuation signals for BDX:
PEG Ratio: 1.46 (69% below median its 10-year median of 4.73)
GF Value™: $191.05 vs. price of $151.38 (20.8% below fair value)
Industry Position: 24.5% below the Medical Devices & Instruments median (#84 of 208)
No single metric tells the full story. See the BDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
76GF Score
Get the complete analysis for BDX
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BDX has been successfully added to your 
